This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Upon completion of this activity, the participant should be able to:
Provided by Evolve Medical Education
Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Evolve designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Faculty:
William F. Mieler, MD
Program Chair
Cless Family Professor and Vice-Chairman
Director, Vitreoretinal Fellowship Training
Department of Ophthalmology & Visual Sciences
University of Illinois at Chicago
Jennifer J. Kang-Mieler, PhD, FARVO
Program Chair
Professor
Department of Biomedical Engineering
Illinois Institute of Technology
Michael Engelbert, MD, PhD
Vitreous Retina Macula Consultants of New York
New York University Grossman School of Medicine
Lawrence A. Yannuzzi, MD
Founder of the Macula Foundation Inc
Professor of Clinical Ophthalmology
Columbia University School of Medicine
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
William F. Mieler, MD, and/or spouse/partner has no financial relationships with commercial interests.
Jennifer J. Kang-Mieler, PhD, FARVO, and/or spouse/partner has no financial relationships with commercial interests.
Michael Engelbert, MD, PhD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Grant/Reasearch Support: Macula Foundation; Consultant and Speaker’s Bureau: Genentech.
Lawrence A. Yannuzzi, MD, and/or spouse/partner has no financial relationships with commercial interests.
The Evolve staff and planners have no financial relationships with commercial interests.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals, Inc.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
